(Q43938257)

28 November 2017

Herpes simplex virus isolates with reduced adefovir susceptibility selected in vivo by foscarnet therapy (English)

1 reference

28 November 2017

2

Guy Boivin

1 reference

28 November 2017

Julie Bestman-Smith

1

1 reference

28 November 2017

1 May 2002

1 reference

Journal of Medical Virology

28 November 2017

1 reference

28 November 2017

67

1 reference

28 November 2017

1

1 reference

28 November 2017

88-91

1 reference

Susceptibilities of several drug-resistant herpes simplex virus type 1 strains to alternative antiviral compounds

28 November 2017

1 reference

Resistance of herpes simplex virus type 1 against different phosphonylmethoxyalkyl derivatives of purines and pyrimidines due to specific mutations in the viral DNA polymerase gene

21 January 2018

1 reference

Characterization of a DNA polymerase mutant of herpes simplex virus from a severely immunocompromised patient receiving acyclovir

21 January 2018

1 reference

Identification of amino acids in herpes simplex virus DNA polymerase involved in substrate and drug recognition

21 January 2018

1 reference

Treatment with intravenous (S)-1-[3-hydroxy-2-(phosphonylmethoxy)propyl]-cytosine of acyclovir-resistant mucocutaneous infection with herpes simplex virus in a patient with AIDS.

21 January 2018

1 reference

A randomized, double-blind, placebo-controlled trial of cidofovir gel for the treatment of acyclovir-unresponsive mucocutaneous herpes simplex virus infection in patients with AIDS.

21 January 2018

1 reference

Successful treatment of an acyclovir- and foscarnet-resistant herpes simplex virus type 1 lesion with intravenous cidofovir

21 January 2018

1 reference

Biochemical basis for increased susceptibility to Cidofovir of herpes simplex viruses with altered or deficient thymidine kinase activity

21 January 2018

1 reference

A controlled trial comparing foscarnet with vidarabine for acyclovir-resistant mucocutaneous herpes simplex in the acquired immunodeficiency syndrome. The AIDS Clinical Trials Group

21 January 2018

1 reference

Foscarnet-resistant herpes simplex virus infection in patients with AIDS.

21 January 2018

1 reference

Characterization of the DNA polymerase and thymidine kinase genesof herpes simplex virus isolates from AIDS patients in whom acyclovirand foscarnet therapy sequentially failed

21 January 2018

1 reference

Successful treatment of progressive mucocutaneous infection due to acyclovir- and foscarnet-resistant herpes simplex virus with (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine (HPMPC).

21 January 2018

1 reference

Properties of a 9-(2-phosphonylmethoxyethyl)adenine (PMEA)-resistant herpes simplex virus type 1 virus mutant

21 January 2018

1 reference

Differential Susceptibility of Several Drug-Resistant Strains of Herpes Simplex Virus Type 2 to Various Antiviral Compounds

21 January 2018

1 reference

A New Topical Treatment for Resistant Herpes Simplex Infections

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/JMV.2195

1 reference

28 November 2017

1 reference

PubMed ID

11920821